WWP
CTXR icon

WR Wealth Planners’s Citius Pharmaceuticals CTXR Stock Holding History

WR Wealth Planners’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$16 Hold
4
– – ﹤0.01% 1095
2024
Q3 		$50 Hold
4
– – ﹤0.01% 1124
2024
Q2 		$58 Hold
4
– – ﹤0.01% 1122
2024
Q1 		$90 Buy
+4
New +$73 ﹤0.01% 1150
2023
Q4 		– Sell
-4
Closed -$68 – 326
2023
Q3 		$68 Hold
4
– – ﹤0.01% 899
2023
Q2 		$120 Hold
4
– – ﹤0.01% 881
2023
Q1 		$117 Buy
+4
New +$115 ﹤0.01% 908

Other funds holding CTXR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return

WR Wealth Planners's CTXR Position: Q4 2024 in Review

WR Wealth Planners held its Citius Pharmaceuticals (CTXR) position steady in Q4 2024 at 4 shares worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #1095.

WR Wealth Planners first reported a position in CTXR in Q1 2023 and has held it in 7 quarters since. The position peaked at $120 in Q2 2023. 30 funds tracked by Wall St. Rank hold CTXR as of Q4 2024.

  • WR Wealth Planners held 4 shares of Citius Pharmaceuticals worth $16 as of Q4 2024.
  • WR Wealth Planners left its Citius Pharmaceuticals share count unchanged in Q4 2024.
  • Citius Pharmaceuticals made up ﹤0.01% of WR Wealth Planners's portfolio in Q4 2024, its #1095 holding.
  • WR Wealth Planners first reported a position in Citius Pharmaceuticals in Q1 2023 and has held it in 7 quarters since.
  • WR Wealth Planners's Citius Pharmaceuticals position peaked at $120 in Q2 2023.
  • 30 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q4 2024.

Based on WR Wealth Planners's 13F filing for Q4 2024, filed 5 Feb 2025.